Association between glucagon-like peptide 1 receptor agonist and sodium—glucose cotransporter 2 inhibitor use and COVID-19 outcomes

Kahkoska, Anna R, Trine Julie Abrahamsen, Caleb Alexander, Tellen D Bennett, Christopher G Chute, Melissa A Haendel, Klara R Klein, et al. 2021. “Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium—glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes”. Diabetes Care 44 (7): 1564-72.